FDA Warns HealthCare Officials to Avoid Metronidazole, Ondansetron, and Ciprofloxacin Use
Food and Drug Administration has directed the healthcare professionals to avoid the use of certain Intravenous Metronidazole, Ondansetron, and Ciprofloxacin due to a fear of contamination.
The warning has come in the wake of the FDA receiving reports on the presence of floating matter in IV bags manufactured by Claris Lifesciences Limited, in Ahmedabad, India. It explained that any foreign matter shall not be present in sterile injectable product.
The report also claimed that potentially affected products are being sold under the Claris, Sagent Pharmaceuticals, Pfizer, and West-Ward Pharmaceuticals labels.
Metronidazole and ciprofloxacin are essentially the antibiotics which are used for the treatment of a variety of infections. Ondansetron is an antiemetic used nausea and vomiting.
A Claris customer reported the presence of white matter in a bag of metronidazole. An analysis on the bag revealed that the matter was a Cladosporium mold. Such molds can cause infections in susceptible patients.
Claris has ordered a recall of all the packs of Metronidazole and ciprofloxacin. All these products are produced with almost the same procedure.
FDA officials are probing the situation. As soon as anything is found, the customers will be notified.
New Zealand News
- Tesla to design & build affordable EV in China: Tom Zhu
- First deliveries of all-electric Porsche in Australia to take place this weekend
- Crown Resorts suffers record six-month loss due to COVID-19 closures
- Australia’s Crown Resorts 'not suitable' for Sydney gaming license: Inquiry Commission
- What Does Phasing Out Cheques Tell Us About Finance in New Zealand?